Literature DB >> 17851671

[Current status of ambulatory rheumatologic health care in Germany. Structure of health care and range of services].

T Mittendorf1, E Edelmann, J Kekow, U von Hinüber, W Müller-Brodmann, J-M Graf von der Schulenburg.   

Abstract

AIM: To gather information on current organizational structures in rheumatologic ambulatory health care in Germany. Based on the results recommendations on future structures will be discussed.
METHODS: This study involved data collection and statistical analysis via a structured 10-page questionnaire among the members of the German Association of Rheumatologists. The questions concerned a variety of topics including information on office structures, patient structure, structure of services offered, co-operation with colleagues and hospitals, quality assurance measures, economic factors, and a subjective assessment of the health care structures in rheumatology by the participants.
RESULTS: Data obtained from 197 rheumatologists who participate in health care were analyzed. In this paper results concerning the organizational as well as the medical ambulatory health care structure will be presented. Data on economic factors will be presented in part 2 of this study.
CONCLUSIONS: The organization of ambulatory treatment regarding processes and treatment differences between office-based physicians and rheumatologic outpatient departments in hospitals was very homogeneous. However, physicians in the eastern regions treated significantly more patients compared with the western parts of Germany. This difference was also observed between the north and south. Differences in patient groups (e.g. underlying diseases) were reported between different sub-groups of rheumatologists (e.g. internal specialists vs. GP vs. orthopedic rheumatologists). Integrated health care, as promoted by German social law, did not play a major role. Overall there was a high level of self-initiated training of physicians and participation in education of patients and other physicians.

Entities:  

Mesh:

Year:  2007        PMID: 17851671     DOI: 10.1007/s00393-007-0189-x

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  2 in total

1.  Guidelines for the management of rheumatoid arthritis: 2002 Update.

Authors: 
Journal:  Arthritis Rheum       Date:  2002-02

Review 2.  Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide.

Authors:  P Emery; F C Breedveld; M Dougados; J R Kalden; M H Schiff; J S Smolen
Journal:  Ann Rheum Dis       Date:  2002-04       Impact factor: 19.103

  2 in total
  6 in total

1.  [Prescription of TNF-alpha inhibitors and regional differences in 2010].

Authors:  R Windt; G Glaeske; F Hoffmann
Journal:  Z Rheumatol       Date:  2011-12       Impact factor: 1.372

2.  [Updated results of a survey on outpatient healthcare structures in rheumatology].

Authors:  T Mittendorf
Journal:  Z Rheumatol       Date:  2010-11       Impact factor: 1.372

Review 3.  [Characteristics and challenges of rheumatology-specific laboratories in practice].

Authors:  U von Hinüber
Journal:  Z Rheumatol       Date:  2016-05       Impact factor: 1.372

4.  [Outpatient rheumatologic treatment in Germany].

Authors:  E Edelmann
Journal:  Z Rheumatol       Date:  2014-03       Impact factor: 1.372

5.  [Healthcare research in rheumatology. Current state].

Authors:  A Zink
Journal:  Z Rheumatol       Date:  2014-03       Impact factor: 1.372

6.  [Current status and perspectives of ambulatory rheumatologic health care in Germany : economic structural conditions and motivation of rheumatologists].

Authors:  T Mittendorf; E Edelmann; J Kekow; U von Hinüber; W Müller-Brodmann; J-M Graf von der Schulenburg
Journal:  Z Rheumatol       Date:  2007-11       Impact factor: 1.372

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.